CPT code 82962: Meter glucose, FDA home-use cleared instrument2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Reports blood glucose measured with a hand-held instrument cleared for home use, distinguishing meter-based testing from laboratory assays and glucose-tolerance tests.
Medicare pays $3.28 for 82962 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$3.28
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 82962 covers
82962 reports a blood glucose measurement made with a hand-held glucose monitoring instrument cleared by the FDA specifically for home use. The defining distinction is the meter-based method, not simply that blood was obtained. It differs from a quantitative laboratory blood glucose assay and from glucose testing performed on another body fluid. Medicare services are reported predominantly in office settings, with fewer facility services.
Report this code for the qualifying hand-held meter test. The CLFS pays one national amount per code in every state and locality, without an office-versus-facility payment difference. The 2026 national CLFS amount is $3.28, unchanged since 2020. Medicare pays the test only through the CLFS; it is excluded from the physician fee schedule.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 82962
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 82962. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 82962 with status X (excluded by statute), so the test itself is paid only from the CLFS.
82962 on the lab fee schedule since 2020
82962 · CLFS 2026 Q4 (current)
$3.28
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
82962 compared with similar tests
- 82947Blood glucoseQuantitative, not reagent strip$3.93
- Choose 82962 for a qualifying hand-held meter measurement; choose 82947 for a quantitative laboratory blood glucose assay.
- 82948Blood glucoseReagent-strip method$5.04
- 82948 identifies a reagent-strip blood glucose test. 82962 identifies a test performed with a hand-held meter cleared for home use.
- 82945Fluid glucoseNonblood specimens$3.93
- 82945 is for glucose measured in a fluid other than blood; 82962 is for a blood glucose measurement with a hand-held meter.
- 82951Glucose toleranceThree specimens$12.87
- 82951 represents glucose-tolerance testing, while 82962 represents a hand-held meter reading rather than a tolerance test.
82962 billing questions
How does 82962 differ from 82947?
82962 is for a blood glucose measurement made with a qualifying hand-held meter. 82947 is for a quantitative blood glucose assay.
Does a fingerstick alone establish that 82962 applies?
No. The code is distinguished by use of a hand-held instrument cleared by the FDA for home use.
How does 82962 differ from 82948?
82962 identifies a hand-held meter test using an instrument cleared for home use; 82948 identifies a reagent-strip blood glucose test.
When is 82951 more appropriate than 82962?
82951 is for glucose-tolerance testing. 82962 is for a hand-held meter blood glucose measurement, not a tolerance test.
Does Medicare pay 82962 through the physician fee schedule?
No. Medicare pays 82962 through the CLFS, with one national amount across localities and no office-versus-facility payment difference.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets
Put 82962 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Build my fee sheet